臺灣人文及社會科學引文索引資料庫系統

:::

詳目顯示

回上一頁
第 1 筆 / 總合 1 筆   第一頁 上一頁 下一頁 最後一頁
/1頁
題名：從SARS到COVID-19看臺灣於藥品專利強制授權之進程
書刊名：月旦醫事法報告
作者：張哲倫
作者(外文)：Chang, Roger
出版日期：2020
卷期：44
頁次：頁64-78
主題關鍵詞：克流感；專利強制授權；最後手段性；新冠肺炎；Tamiflu；Compulsory licensing；Policy tool of last resort；COVID-19
原始連結：連回原系統網址new window
相關次數：
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:2
期刊論文
1.Lemley, Mark A.(2004)。Ex Ante versus Ex Post Justifications for Intellectual Property。University of Chicago Law Review，71，129-149。  new window
2.Bird, Robert、Cahoy, Daniel R.(2008)。The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach。American Business Law Journal，45(2)，283-330。  new window
3.Kapczynski, Amy(2009)。Harmonization and its Discontents: A Case Study of TRIPS Implementation in India's Pharmaceutical Sector。California Law Review，97，1571-1650。  new window
4.謝富旭、徐右螢(20200504)。決戰武漢肺炎，採訪陽明大學校長郭旭崧。今周刊，2020(5月號)。  延伸查詢new window
5.彭子珊(20200309)。新冠肺炎唯一解藥「瑞德西韋」，上市前的2大難關。天下雜誌，693。  延伸查詢new window
6.張哲倫(20191200)。專利連結制度運作之基石--醫藥專利的本質及法院扮演的關鍵角色。月旦醫事法報告，38，20-34。new window  延伸查詢new window
7.Cahoy, Daniel R.(2011)。Breaking Patents。The Michigan Journal of International Law，32(3)，461-509。  new window
8.McNeely, Richard J.(2008)。Comment, Governmental Indirect Patent Infringement: The Need to Hold Uncle Sam Accountable Under 28 U.S.C. § 1498。The Capital University Law Review，36，1065-1130。  new window
9.Cahoy, Daniel R.(2002)。Treating the Legal Side Effects of Cipro®: are Evaluation of Compensation Rules for Government Takings of Patent Rights。American Business Law Journal，40，125-175。  new window
10.Rimmer, Matthew(2009)。The Road to Copenhagen: Intellectual Property and Climate Change。Journal of Intellectual Property Law & Practice，4，784-788。  new window
11.Castellano, Richard A.(2006)。Note, Patent Law for New Medical Uses of Known Compounds and Pfizer's Viagra Patent。Idea，46，283-316。  new window
12.Bagley, Margo A.(2018)。The morality of compulsory licensing as an access to medicines tool。Minnesota Law Review，102，2463-2495。  new window
13.Epstein, Richard A.、Kieff, F. Scott(2011)。Questioning the Frequency and Wisdom of Compulsory Licensing for Pharmaceutical Patents。The University of Chicago Law Review，78，71-93。  new window
14.Adelstein, Richard(2002)。Equity and Efficiency in Markets for Ideas。Connecticut Journal of International Law，17，249-261。  new window
15.Mullin, Thomas F.(2002)。AIDS, anthrax, and compulsory licensing: has the United States learned anything?: a comment on recent decisions on the international intellectual property rights of pharmaceutical patents。ILSA Journal of International & Comparative Law，9(1)，185-209。  new window
16.Abbott, Frederick M.、Reichman, Jerome H.(2007)。The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPs Provisions。Journal of International Economic Law，10(4)，921-988。  new window
圖書
1.Global Forum for Health Research(2006)。Monitoring Financial Flows for Health Research 2005: Behind the Global Numbers。  new window
2.Valdivieso, Jeanneth(20091028)。Ecuador to Make Cheap Versions of Patented Drugs。Associated Press。  new window
3.Correa, Carlos M.(1999)。Intellectual Property Rights and the Use of Compulsory Licenses: Options for Developing Countries。  new window
其他
1.游昌樺，陳煜彬(20200319)。防疫作戰--搶時間合成瑞德西韋，產學防疫兼練兵，https://udn.com/news/story/120940/4427235。  延伸查詢new window
2.陽明與交通大學、臺北榮民總醫院因應新型冠狀病毒疫情組成的防疫聯盟，考量目前疫情發展急需抗病毒藥物，已與心悅生醫、臺耀化學兩家生技公司簽訂合作備忘錄，https://web.ym.edu.tw/m/404-1133-43040.php?Lang=zh-tw。  延伸查詢new window
3.柯皓翔，陳潔(20200402)。COVID-19三大希望之藥，臺灣全數備戰到位--「法匹拉韋」臺製藥原料啟動，東南亞多國都想要，https://www.twreporter.org/a/covid-19-mit-medicine-favipiravh。  延伸查詢new window
4.王玉樹(20200416)。醫界籲強制授權助呼吸器國家隊，https://www.chinatimes.com/newspapers/20200416000594-260110?chdtv。  延伸查詢new window
5.Chhabara, Rajesh(20080917)。Climate Ready GM Crops: The Patent Race，http://www.climatechangecorp.com/content.asp?ContentID=5644。  new window
6.(20091123)。China, India Push for 'Patent Fee' Green Tech，https://www.euractiv.com/section/innovation-industry/news/china-india-push-for-patent-free-green-tech/。  new window
7.Allam, Abeer(20021004)。Seeking Investment, Egypt Tries Patent Laws。  new window
8.Zamiska, Nicholas(20070130)。Thai Move to Trim Drug Costs Highlights Growing Patent Rift。  new window
9.Cass, Ronald A.(20070828)。Patent Remedy。  new window
10.Basheer, Shamnad(20150427)。Bayer's Nexavar, Patent Working and Compulsory Licensing: Mind the (Information) Gap!，https://spicyip.com/2015/04/bayers-nexavar-patent-working-and-compulsory-licensing-mind-the-information-gap.html。  new window
11.(20051026)。國家衛生研究院電子報，http://enews2.nhri.org.tw/enews_css_list_new3.php?volume_indx=122&enews_dt=2005-10-26。  new window
12.(2019)。How Big Pharma Sabotaged the Struggle for Affordable Cancer Treatment, Novartis vs. Colombia，https://corporateeurope.org/sites/default/files/2019-06/Novartis%20vs%20Colombia.pdf。  new window
13.(20150526)。Letter from Livia Leu, Swiss Ambassador and Head of Bilateral Economic Relations Delegate of the Federal Council for Trade Agreements, to Dr. Carolina Gomez, Adviser, Colombian Ministry of Health and Social Protection，https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/patent-of-lmatinib-glive-closing-arguments.pdf。  new window
14.O'Day, Daniel(20200404)。An Update on COVID-19 from our Chairman & CEO，https://www.gilead.com/stories/articles/an-update-on-covid-19-from-our-chairman-and-ceo。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE

臺灣人文及社會科學引文索引資料庫

目前上線人數：1406（臺灣：1388，外國：18） ／ 本年度總使用人次：2488187 ／ 訪客人次（自102年09月）：68303268
國家圖書館著作權聲明 Copyright © 2013 All rights reserved.
本館地址: 100201臺北市中山南路20號． 本館地圖及交通資訊．
總機：(02)23619132．最佳瀏覽解析度為1024x768以上